| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $0.23 (Miss by $-0.02) |
| EPS GAAP Actual | $0.23 (Miss by $-0.02) |
| Revenue Actual | $0.554567B |
| Revenue Surprise | Beat by $554.567M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0.15 | 142.93 | 0.12854 | 0.16735 | 1 |
| Dec 2028 | 0.27 | 79.41 | 0.25685 | 0.28047 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.42 | 0.42 | 0.554567B | 43.47% | 554.57M |
| FQ2 2025 (Jun 2025) | 0.11 | 0.11 | 0.48065B | 53.81% | 480.65M |
| FQ1 2025 (Mar 2025) | 0.06 | 0.06 | 0.360062B | 40.83% | 360.06M |
| FQ4 2024 (Dec 2024) | 0.0961 | 0.0961 | 0.305444B | 14.19% | 305.44M |
| FQ3 2024 (Sep 2024) | 0.255 | 0.255 | 0.313476B | 37.93% | 313.48M |
| FQ2 2024 (Jun 2024) | 0 | 0 | 0.222026B | 20.17% | 222.03M |
| FQ1 2024 (Mar 2024) | -0.08 | -0.08 | 0.21306B | 12.09% | 213.06M |
| FQ4 2023 (Dec 2023) | -0.067 | -0.067 | 0.26209B | 19.83% | 262.09M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.46 | -- | 0.46 | 0.46 | 1 |
| FQ3 2027 (Sep 2027) | 0.48 | -- | 0.48 | 0.48 | 1 |
| FQ2 2027 (Jun 2027) | 0.5 | -- | 0.5 | 0.5 | 1 |
| FQ1 2027 (Mar 2027) | 0.54 | -- | 0.54 | 0.54 | 1 |
| FQ4 2026 (Oct 2026) | 0.0661 | -- | 0.0661 | 0.0661 | 0 |
| FQ3 2026 (Jul 2026) | 0.0683 | -514.93 | 0.0683 | 0.0683 | 0 |
| FQ2 2026 (Jun 2026) | 0.42 | 73.81 | 0.42 | 0.42 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.82B | -- | 0.82B | 0.82B | 1 |
| FQ3 2027 (Sep 2027) | 0.81B | -- | 0.81B | 0.81B | 1 |
| FQ2 2027 (Jun 2027) | 0.8B | -- | 0.8B | 0.8B | 1 |
| FQ1 2027 (Mar 2027) | 0.78B | -- | 0.78B | 0.78B | 1 |
| FQ4 2026 (Oct 2026) | 0.27B | -- | 0.27B | 0.27B | 0 |
| FQ3 2026 (Jul 2026) | 0.27B | -107.02 | 0.27B | 0.27B | 0 |
| FQ2 2026 (Jun 2026) | 0.69B | 29.86 | 0.69B | 0.69B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.42 | 0.42 | 100% | |
| FQ2 2025 (Jun 2025) | 0.11 | 0.11 | 100% | |
| FQ1 2025 (Mar 2025) | 0.06 | 0.06 | 100% | |
| FQ4 2024 (Dec 2024) | 0.0961 | 0.0961 | 100% | |
| FQ3 2024 (Sep 2024) | 0.255 | 0.255 | 100% | |
| FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | -0.08 | -0.08 | 100% | |
| FQ4 2023 (Dec 2023) | -0.067 | -0.067 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.55B | $554.57M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.48B | $480.65M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.36B | $360.06M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.31B | $305.44M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.31B | $313.48M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.22B | $222.03M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.21B | $213.06M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.26B | $262.09M | 100% |